In late 2025, the Parkinson’s Foundation and the Fixel Institute at the University of Florida brought together dozens of…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
A real-world study found that psychiatric issues, including hallucinations and delusions, developed in some people with…
Chemical changes in the brain region known as the cerebellum may play a key role in the cognitive issues …
The U.S. Food and Drug Administration (FDA) has approved tavapadon — an oral drug aimed at maintaining consistent control of…
A rehabilitation program called PD-CoRE was shown to help adults with Parkinson’s disease improve their cognitive function and lessen…
Demographics, social experiences, mental health, and sexual well-being are among factors playing significant roles in shaping health-related quality of life…
Incorporating a theory focused on maximizing patients’ motivation may enhance the effectiveness of rehabilitation aimed at improving lung function in…
A new first-in-class treatment for Parkinson’s disease, designed to get past the brain’s protective barrier, was shown to be…
A team of U.S. scientists has compiled a large data set of remotely collected data from people with and without…
A compound derived from a Himalayan herb may help boost the effectiveness of levodopa in Parkinson’s disease, according to…